MED Relative Valuation - Medifast Inc

Watchlist Manager

Watchlist

Price: 10 USD -0.7% Market Closed

Market Cap: $109.9m

	Medifast Inc NYSE:MED	US
	Daqo New Energy Corp NYSE:DQ	CN
	Gabriel India Ltd NSE:GABRIEL	IN
	World Holdings Co Ltd TSE:2429	JP
	CorVel Corp NASDAQ:CRVL	US
	Sohu.com Ltd NASDAQ:SOHU	CN
D	Didim E&F Inc KOSDAQ:217620	KR
Z	ZRP Printing Group Co Ltd SZSE:301223	CN
Y	Yandex NV F:YDX	NL
V	Vistamalls Inc XPHS:STR	PH
B	Baker Hughes Co NASDAQ:BKR	US
P	Pennant Group Inc NASDAQ:PNTG	US
	DP Aircraft I Ltd LSE:DPA	GG
F	Forise International Ltd SGX:8A1	SG
	Killbuck Bancshares Inc OTC:KLIB	US

Relative Value

The Relative Value of one MED stock under the Base Case scenario is hidden USD. Compared to the current market price of 10 USD, Medifast Inc is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

What is Relative Valuation?

How is Relative Value calculated?

MED Relative Value

Show

Worst Case

Base Case

Best Case

Valuation Multiples

View Details

Multiples Across Competitors

All Multiples

P/S

P/E

EV/EBITDA

EV/EBIT

Forward Multiples

		Market Cap	P/S	P/E	EV/EBITDA	EV/EBIT
US	Medifast Inc NYSE:MED	109.9m USD	0.3	-5.9	-1 986.3	4.1
FR	L'Oreal SA PAR:OR	185.3B EUR	4.1	29.7	18	21.9
UK	Unilever PLC LSE:ULVR	100.5B GBP	2.3	12.2	12.2	13.8
IN	Hindustan Unilever Ltd NSE:HINDUNILVR	4.9T INR	7.5	33.5	32.1	35.5
UK	HALEON PLC LSE:HLN	33.8B GBP	3	19.9	13.8	15.8
US	Estee Lauder Companies Inc NYSE:EL	31.1B USD	2.1	-174.6	15.9	25.1
DE	Beiersdorf AG XETRA:BEI	16.1B EUR	1.6	17	7.9	9.8
JP	Kao Corp TSE:4452	2.7T JPY	1.6	22.6	10.3	15.7
IN	Godrej Consumer Products Ltd NSE:GODREJCP	1T INR	6.7	55.8	33.7	36.8
CA	Relevium Technologies Inc XTSX:RLV	12.2B CAD	855.7	-4 624.4	-6 373.4	-6 360.4
IN	Dabur India Ltd NSE:DABUR	763.9B INR	5.8	40.5	29.4	36.2

			Revenue Growth	P/S to Growth
US	Medifast Inc NYSE:MED	Average P/S: 81 0.3	N/A	N/A
FR	L'Oreal SA PAR:OR	4.1	6%	0.7
UK	Unilever PLC LSE:ULVR	2.3	3%	0.8
IN	Hindustan Unilever Ltd NSE:HINDUNILVR	7.5	7%	1.1
UK	HALEON PLC LSE:HLN	3	5%	0.6
US	Estee Lauder Companies Inc NYSE:EL	2.1	6%	0.4
DE	Beiersdorf AG XETRA:BEI	1.6	5%	0.3
JP	Kao Corp TSE:4452	1.6	4%	0.4
IN	Godrej Consumer Products Ltd NSE:GODREJCP	6.7	10%	0.7
CA	Relevium Technologies Inc XTSX:RLV	855.7	N/A	N/A
IN	Dabur India Ltd NSE:DABUR	5.8	8%	0.7

			Earnings Growth	PEG
US	Medifast Inc NYSE:MED	Average P/E: 28.9 Negative Multiple: -5.9	N/A	N/A
FR	L'Oreal SA PAR:OR	29.7	13%	2.3
UK	Unilever PLC LSE:ULVR	12.2	-6%	N/A
IN	Hindustan Unilever Ltd NSE:HINDUNILVR	33.5	7%	4.8
UK	HALEON PLC LSE:HLN	19.9	11%	1.8
US	Estee Lauder Companies Inc NYSE:EL	Negative Multiple: -174.6	N/A	N/A
DE	Beiersdorf AG XETRA:BEI	17	10%	1.7
JP	Kao Corp TSE:4452	22.6	10%	2.3
IN	Godrej Consumer Products Ltd NSE:GODREJCP	55.8	18%	3.1
CA	Relevium Technologies Inc XTSX:RLV	Negative Multiple: -4 624.4	N/A	N/A
IN	Dabur India Ltd NSE:DABUR	40.5	11%	3.7

			EBITDA Growth	EV/EBITDA to Growth
US	Medifast Inc NYSE:MED	Average EV/EBITDA: 19.3 Negative Multiple: -1 986.3	N/A	N/A
FR	L'Oreal SA PAR:OR	18	8%	2.3
UK	Unilever PLC LSE:ULVR	12.2	4%	3
IN	Hindustan Unilever Ltd NSE:HINDUNILVR	32.1	7%	4.6
UK	HALEON PLC LSE:HLN	13.8	7%	2
US	Estee Lauder Companies Inc NYSE:EL	15.9	16%	1
DE	Beiersdorf AG XETRA:BEI	7.9	6%	1.3
JP	Kao Corp TSE:4452	10.3	8%	1.3
IN	Godrej Consumer Products Ltd NSE:GODREJCP	33.7	12%	2.8
CA	Relevium Technologies Inc XTSX:RLV	Negative Multiple: -6 373.4	N/A	N/A
IN	Dabur India Ltd NSE:DABUR	29.4	11%	2.7

			EBIT Growth	EV/EBIT to Growth
US	Medifast Inc NYSE:MED	Average EV/EBIT: 21.5 4.1	N/A	N/A
FR	L'Oreal SA PAR:OR	21.9	10%	2.2
UK	Unilever PLC LSE:ULVR	13.8	4%	3.5
IN	Hindustan Unilever Ltd NSE:HINDUNILVR	35.5	8%	4.4
UK	HALEON PLC LSE:HLN	15.8	8%	2
US	Estee Lauder Companies Inc NYSE:EL	25.1	26%	1
DE	Beiersdorf AG XETRA:BEI	9.8	4%	2.5
JP	Kao Corp TSE:4452	15.7	N/A	N/A
IN	Godrej Consumer Products Ltd NSE:GODREJCP	36.8	13%	2.8
CA	Relevium Technologies Inc XTSX:RLV	Negative Multiple: -6 360.4	N/A	N/A
IN	Dabur India Ltd NSE:DABUR	36.2	11%	3.3

Medifast Inc
NYSE:MED

Relative Value

Valuation Multiples

Multiples Across Competitors

MED Competitors Multiples
Medifast Inc Competitors

See Also

Company

Help

Tools

Stocks

Medifast Inc NYSE:MED

Relative Value

Valuation Multiples

Multiples Across Competitors

MED Competitors Multiples Medifast Inc Competitors

See Also

Company

Help

Tools

Stocks

Medifast Inc
NYSE:MED

MED Competitors Multiples
Medifast Inc Competitors